Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Testosterone therapy and venous thromboembolism: A systematic review and meta-analysis
Damon E. Houghton, Mouaz Alsawas, Patricia Barrioneuvo, et al.
Thrombosis Research (2018) Vol. 172, pp. 94-103
Open Access | Times Cited: 68

Showing 1-25 of 68 citing articles:

Association of Testosterone Therapy With Risk of Venous Thromboembolism Among Men With and Without Hypogonadism
Rob F. Walker, Neil A. Zakai, Richard F. MacLehose, et al.
JAMA Internal Medicine (2019) Vol. 180, Iss. 2, pp. 190-190
Open Access | Times Cited: 109
Effects of long-term testosterone treatment on cardiovascular outcomes in men with hypogonadism: Rationale and design of the TRAVERSE study
Shalender Bhasin, A. Michael Lincoff, Shehzad Basaria, et al.
American Heart Journal (2021) Vol. 245, pp. 41-50
Open Access | Times Cited: 61
Testosterone Therapy: What We Have Learned From Trials
Giovanni Corona, Luiz Otávio Torres, Mario Maggi
The Journal of Sexual Medicine (2020) Vol. 17, Iss. 3, pp. 447-460
Open Access | Times Cited: 63
Efficacy and Safety of Testosterone Treatment in Men: An Evidence Report for a Clinical Practice Guideline by the American College of Physicians
Susan J. Diem, Nancy Greer, Roderick MacDonald, et al.
Annals of Internal Medicine (2020) Vol. 172, Iss. 2, pp. 105-105
Closed Access | Times Cited: 53
Society of Family Planning clinical recommendations: Contraceptive counseling for transgender and gender diverse people who were female sex assigned at birth
A. Bonnington, Shokoufeh Dianat, Jennifer Kerns, et al.
Contraception (2020) Vol. 102, Iss. 2, pp. 70-82
Open Access | Times Cited: 50
Cardiovascular Risk Associated With Gender Affirming Hormone Therapy in Transgender Population
Gloria Aranda, Irene Halperín, Esther Gómez‐Gil, et al.
Frontiers in Endocrinology (2021) Vol. 12
Open Access | Times Cited: 41
The effect of transdermal gender-affirming hormone therapy on markers of inflammation and hemostasis
Moya Henriëtte Schutte, Robert Kleemann, Nienke M. Nota, et al.
PLoS ONE (2022) Vol. 17, Iss. 3, pp. e0261312-e0261312
Open Access | Times Cited: 34
Benefits and Risks of Testosterone Treatment in Men with Age-Related Decline in Testosterone
Marcelo Rodrigues dos Santos, Shalender Bhasin
Annual Review of Medicine (2020) Vol. 72, Iss. 1, pp. 75-91
Closed Access | Times Cited: 47
Recommendations on the diagnosis, treatment and monitoring of testosterone deficiency in men
Bruno Lunenfeld, George Mskhalaya, Michael Zitzmann, et al.
The Aging Male (2021) Vol. 24, Iss. 1, pp. 119-138
Open Access | Times Cited: 40
Cardiovascular risk and testosterone – from subclinical atherosclerosis to lipoprotein function to heart failure
Bariş Gencer, Marco Bonomi, Maria Pia Adorni, et al.
Reviews in Endocrine and Metabolic Disorders (2021) Vol. 22, Iss. 2, pp. 257-274
Open Access | Times Cited: 33
Perioperative Care of Transgender and Gender-Diverse Patients: A Biopsychosocial Approach
Kyle Sanchez, Raoul A. Sanchez, Bertha Ben Khallouq, et al.
Anesthesia & Analgesia (2023)
Closed Access | Times Cited: 13
Cardiovascular disease in transgendered people: A review of the literature and discussion of risk
Leighton Seal
JRSM Cardiovascular Disease (2019) Vol. 8
Open Access | Times Cited: 38
Testosterone replacement therapy and the risk of venous thromboembolism: A systematic review and meta-analysis of randomized controlled trials
Henok Tadesse Ayele, Vanessa C. Brunetti, Christel Renoux, et al.
Thrombosis Research (2021) Vol. 199, pp. 123-131
Open Access | Times Cited: 32
Effects of Exogenous Androgens on Platelet Activity and Their Thrombogenic Potential in Supraphysiological Administration: A Literature Review
Adrian Roșca, Ana‐Maria Vlădăreanu, Alina Mititelu, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 1, pp. 147-147
Open Access | Times Cited: 29
Gender- and Sexual Orientation– Based Inequities: Promoting Inclusion, Visibility, and Data Accuracy in Oncology
Ash B. Alpert, NFN Scout, Matthew B. Schabath, et al.
American Society of Clinical Oncology Educational Book (2022), Iss. 42, pp. 542-558
Open Access | Times Cited: 22
Sex‐specific aspects of venous thromboembolism: What is new and what is next?
Luuk J.J. Scheres, Astrid van Hylckama Vlieg, Suzanne C. Cannegieter
Research and Practice in Thrombosis and Haemostasis (2022) Vol. 6, Iss. 4, pp. e12722-e12722
Open Access | Times Cited: 19
Efficacy of Topical Tranexamic Acid in Gender-Affirming Mastectomy
Israel Falade, Alex Lopes, Kayla Switalla, et al.
Journal of Plastic Reconstructive & Aesthetic Surgery (2025)
Closed Access
Riesgo de tromboembolia venosa en población transgénero en terapia hormonal: una revisión sistemática y metaanálisis
Anabel Franco‐Moreno, Pablo Ryan, Nuria Muñoz‐Rivas, et al.
Medicina Clínica (2025) Vol. 164, Iss. 12, pp. 106921-106921
Closed Access
Testosterone Therapy, Thrombophilia, Venous Thromboembolism, and Thrombotic Events
Charles J. Glueck, Naila Goldenberg, Ping Wang
Journal of Clinical Medicine (2018) Vol. 8, Iss. 1, pp. 11-11
Open Access | Times Cited: 35
Perioperative Transgender Hormone Management: Avoiding Venous Thromboembolism and Other Complications
Rayisa Hontscharuk, Brandon Alba, Catherine S. Manno, et al.
Plastic & Reconstructive Surgery (2021) Vol. 147, Iss. 4, pp. 1008-1017
Closed Access | Times Cited: 23
EMAS position statement: Testosterone replacement therapy in older men
George Kanakis, Riccardo Pofi, Dimitrios G. Goulis, et al.
Maturitas (2023) Vol. 178, pp. 107854-107854
Open Access | Times Cited: 8
Androgen-Regulated Cardiac Metabolism in Aging Men
Genaro Barrientos, Paola Llanos, Carla Basualto-Alarcón, et al.
Frontiers in Endocrinology (2020) Vol. 11
Open Access | Times Cited: 22
Late‐onset hypogonadism: Reductio ad absurdum of the cardiovascular risk‐benefit of testosterone replacement therapy
Franz Sesti, Riccardo Pofi, Marianna Minnetti, et al.
Andrology (2020) Vol. 8, Iss. 6, pp. 1614-1627
Open Access | Times Cited: 22
Controversies in Testosterone Therapy
David K. Twitchell, Alexander W. Pastuszak, Mohit Khera
Sexual Medicine Reviews (2020) Vol. 9, Iss. 1, pp. 149-159
Closed Access | Times Cited: 22
Glucocorticoids and Risk of Venous Thromboembolism in Asthma Patients Aged 20–59 Years in the United Kingdom’s CPRD 1995–2015
Olulade Ayodele, Howard Cabral, David D. McManus, et al.
Clinical Epidemiology (2022) Vol. Volume 14, pp. 83-93
Open Access | Times Cited: 12
Page 1 - Next Page

Scroll to top